BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muratore F, Crescentini F, Spaggiari L, Pazzola G, Casali M, Boiardi L, Pipitone N, Croci S, Galli E, Aldigeri R, Versari A, Salvarani C. Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT. Semin Arthritis Rheum 2019;48:1074-82. [PMID: 30424972 DOI: 10.1016/j.semarthrit.2018.10.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Clifford AH. Cardiovascular Disease in Large Vessel Vasculitis. Rheumatic Disease Clinics of North America 2023;49:81-96. [DOI: 10.1016/j.rdc.2022.08.004] [Reference Citation Analysis]
2 Dumont A, Labombarda F, Gallou S, Deshayes S, Nguyen A, Boutemy J, Martin-silva N, Maigné G, Aouba A, de Boysson H. Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis. Seminars in Arthritis and Rheumatism 2022;57:152117. [DOI: 10.1016/j.semarthrit.2022.152117] [Reference Citation Analysis]
3 Jamar F, Gormsen LC, Yildiz H, Slart RH, van der Geest KS, Gheysens O. The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response. Q J Nucl Med Mol Imaging 2022;66. [DOI: 10.23736/s1824-4785.22.03465-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Bond M, Tomelleri A, Buttgereit F, Matteson EL, Dejaco C. Looking ahead: giant-cell arteritis in 10 years time. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210963. [DOI: 10.1177/1759720x221096366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lutter G, Puehler T, Röcken C, Both M. Magnetic resonance imaging-based diagnosis of aortitis preceding development of a thoracic aneurysm in a patient with giant cell arteritis: a case report. European Heart Journal - Case Reports 2022;6. [DOI: 10.1093/ehjcr/ytac152] [Reference Citation Analysis]
6 de Boysson H, Aouba A. An Updated Review of Cardiovascular Events in Giant Cell Arteritis. J Clin Med 2022;11:1005. [PMID: 35207277 DOI: 10.3390/jcm11041005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Besutti G, Muratore F, Mancuso P, Ferrari M, Galli E, Spaggiari L, Monelli F, Casali M, Versari A, Boiardi L, Marvisi C, Ligabue G, Pattacini P, Giorgi Rossi P, Salvarani C. Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study. RMD Open 2022;8:e001977. [PMID: 34987095 DOI: 10.1136/rmdopen-2021-001977] [Reference Citation Analysis]
8 Tomelleri A, van der Geest KSM, Sebastian A, van Sleen Y, Schmidt WA, Dejaco C, Dasgupta B. Disease stratification in giant cell arteritis to reduce relapses and prevent long-term vascular damage. The Lancet Rheumatology 2021;3:e886-95. [DOI: 10.1016/s2665-9913(21)00277-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Carvajal Alegria G, van Sleen Y, Graver JC, Sandovici M, Devauchelle-pensec V, Brouwer E, Cornec D. Atteinte de l’aorte dans l’artérite à cellules géantes. Revue du Rhumatisme 2021;88:405-409. [DOI: 10.1016/j.rhum.2021.05.003] [Reference Citation Analysis]
10 Raynor WY, Park PSU, Borja AJ, Sun Y, Werner TJ, Ng SJ, Lau HC, Høilund-Carlsen PF, Alavi A, Revheim ME. PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders. Diagnostics (Basel) 2021;11:2234. [PMID: 34943473 DOI: 10.3390/diagnostics11122234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Imai S, Tahara N, Igata S, Tahara A, Bekki M, Sugiyama Y, Maeda-Ogata S, Honda A, Otsuka H, Ushijima T, Okabe Y, Kaida H, Abe T, Tanaka H, Fukumoto Y, Tayama E. Vascular/perivascular inflammation in IgG4-related disease. J Nucl Cardiol 2021. [PMID: 34704218 DOI: 10.1007/s12350-021-02812-6] [Reference Citation Analysis]
12 Jud P, Verheyen N, Dejaco C, Haas E, Szolar D, Meinitzer A, Duftner C, Thonhofer R, Gressenberger P, Brodmann M, Hafner F. Prevalence and prognostic factors for aortic dilatation in giant cell arteritis – a longitudinal study. Seminars in Arthritis and Rheumatism 2021;51:911-8. [DOI: 10.1016/j.semarthrit.2020.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 de Mornac D, Agard C, Hardouin JB, Hamidou M, Connault J, Masseau A, Espitia-Thibault A, Artifoni M, Ngohou C, Perrin F, Graveleau J, Durant C, Pottier P, Néel A, Espitia O. Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis. Ther Adv Musculoskelet Dis 2021;13:1759720X211006967. [PMID: 34249150 DOI: 10.1177/1759720X211006967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Betrains A, Blockmans D. Diagnostic Approaches for Large Vessel Vasculitides. Open Access Rheumatol 2021;13:153-65. [PMID: 34113183 DOI: 10.2147/OARRR.S282605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hellmich B. [Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?]. Z Rheumatol 2021;80:322-31. [PMID: 33710440 DOI: 10.1007/s00393-021-00975-8] [Reference Citation Analysis]
16 Pipitone N. Histopathology and Imaging. Large and Medium Size Vessel and Single Organ Vasculitis 2021. [DOI: 10.1007/978-3-030-67175-4_5] [Reference Citation Analysis]
17 Berti A, Moura MC, Sechi E, Squizzato F, Costanzo G, Chen JJ, Warrington KJ. Beyond Giant Cell Arteritis and Takayasu's Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers. Curr Rheumatol Rep 2020;22:88. [PMID: 33159612 DOI: 10.1007/s11926-020-00965-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
18 Hellmich B, Águeda AF, Monti S, Luqmani R. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future. Curr Rheumatol Rep 2020;22:84. [PMID: 33044642 DOI: 10.1007/s11926-020-00964-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Koster MJ, Crowson CS, Labarca C, Warrington KJ. Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis. Scand J Rheumatol 2021;50:239-42. [PMID: 32940110 DOI: 10.1080/03009742.2020.1786855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Muratore F, Boiardi L, Restuccia G, Cavazza A, Catanoso M, Macchioni P, Spaggiari L, Cimino L, Aldigeri R, Pipitone N, Fontana A, Casali M, Croci S, Salvarani C. Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study. Seminars in Arthritis and Rheumatism 2020;50:549-58. [DOI: 10.1016/j.semarthrit.2020.04.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
21 Carvajal Alegria G, van Sleen Y, Graver JC, Sandovici M, Devauchelle-Pensec V, Brouwer E, Cornec D. Aortic involvement in giant cell arteritis. Joint Bone Spine 2021;88:105045. [PMID: 32649986 DOI: 10.1016/j.jbspin.2020.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Galli E, Muratore F, Boiardi L, Restuccia G, Cavazza A, Catanoso M, Macchioni P, Spaggiari L, Casali M, Pipitone N, Fontana A, Girolimetto N, Croci S, Salvarani C. Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy. Semin Arthritis Rheum 2020;50:1064-72. [PMID: 32911285 DOI: 10.1016/j.semarthrit.2020.05.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Opoka-Winiarska V, Tomaszek MB, Sobiesiak A, Rybkowska A, Lejman M, Jaszczuk L, Woźniak MM, Zielonka-Lamparska E, Chrapko B. The importance of FDG PET/CT in the diagnostic process of the middle aortic syndrome in a 15-year-old boy patient with suspected systemic vasculitis and final diagnosis of Williams-Beuren syndrome. Rheumatol Int 2020;40:1309-16. [PMID: 32239321 DOI: 10.1007/s00296-020-04550-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Taimen K, Heino S, Kohonen I, Relas H, Huovinen R, Hänninen A, Pirilä L. Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review. Rheumatol Adv Pract 2020;4:rkaa004. [PMID: 32128475 DOI: 10.1093/rap/rkaa004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
25 Davidovic L, Tsay V. Potential Application of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression for Disease Activity Assessment in Takayasu Arteritis—In Search of the “Golden Mean”: Case Report. Annals of Vascular Surgery 2019;61:468.e9-468.e12. [DOI: 10.1016/j.avsg.2019.04.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Blockmans D, Luqmani R, Spaggiari L, Salvarani C. Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis. Autoimmun Rev 2019;18:102405. [PMID: 31648043 DOI: 10.1016/j.autrev.2019.102405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
27 Nguyen AD, Crowhurst T, Lester S, Dobson R, Bartholomeusz D, Hill C. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit. Int J Rheum Dis 2019;22:1378-82. [DOI: 10.1111/1756-185x.13617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Signore A, Lauri C, Auletta S, Anzola K, Galli F, Casali M, Versari A, Glaudemans AWJM. Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology. J Clin Med 2019;8:E681. [PMID: 31091813 DOI: 10.3390/jcm8050681] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]